144 related articles for article (PubMed ID: 31691056)
1. CCL5 protein level: influence on breast cancer staging and lymph nodes commitment.
Derossi DR; Amarante MK; Guembarovski RL; de Oliveira CEC; Suzuki KM; Watanabe MAE; de Syllos Cólus IM
Mol Biol Rep; 2019 Dec; 46(6):6165-6170. PubMed ID: 31691056
[TBL] [Abstract][Full Text] [Related]
2. C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskór BM; Borowik-Zaręba A; Ławicki S
Acta Biochim Pol; 2020 Nov; 67(4):539-449. PubMed ID: 33245226
[TBL] [Abstract][Full Text] [Related]
3. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
[TBL] [Abstract][Full Text] [Related]
5. Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells.
Yamaguchi M; Takagi K; Narita K; Miki Y; Onodera Y; Miyashita M; Sasano H; Suzuki T
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671956
[TBL] [Abstract][Full Text] [Related]
6. The potential to target CCL5/CCR5 in breast cancer.
Velasco-Velázquez M; Xolalpa W; Pestell RG
Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
[TBL] [Abstract][Full Text] [Related]
7. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
[TBL] [Abstract][Full Text] [Related]
8. Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
[TBL] [Abstract][Full Text] [Related]
9. The chemokine CCL5 induces CCR1-mediated hyperalgesia in mice inoculated with NCTC 2472 tumoral cells.
Pevida M; Lastra A; Meana Á; Hidalgo A; Baamonde A; Menéndez L
Neuroscience; 2014 Feb; 259():113-25. PubMed ID: 24316469
[TBL] [Abstract][Full Text] [Related]
10. Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor‑associated macrophages.
An G; Wu F; Huang S; Feng L; Bai J; Gu S; Zhao X
Oncol Rep; 2019 Dec; 42(6):2499-2511. PubMed ID: 31578575
[TBL] [Abstract][Full Text] [Related]
11. Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy.
Nie Y; Huang H; Guo M; Chen J; Wu W; Li W; Xu X; Lin X; Fu W; Yao Y; Zheng F; Luo ML; Saw PE; Yao H; Song E; Hu H
Clin Cancer Res; 2019 Jul; 25(13):3873-3886. PubMed ID: 30890553
[TBL] [Abstract][Full Text] [Related]
12. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.
Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J
Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151
[TBL] [Abstract][Full Text] [Related]
13. The CCL5/CCR5 Chemotactic Pathway Promotes Perineural Invasion in Salivary Adenoid Cystic Carcinoma.
Gao T; Shen Z; Ma C; Li Y; Kang X; Sun M
J Oral Maxillofac Surg; 2018 Aug; 76(8):1708-1718. PubMed ID: 29549020
[TBL] [Abstract][Full Text] [Related]
14. CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer.
Banin-Hirata BK; Losi-Guembarovski R; Oda JM; de Oliveira CE; Campos CZ; Mazzuco TL; Borelli SD; Ceribelli JR; Watanabe MA
Clin Exp Med; 2016 May; 16(2):139-45. PubMed ID: 25716470
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
[TBL] [Abstract][Full Text] [Related]
16. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
Gao D; Cazares LH; Fish EN
BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
[TBL] [Abstract][Full Text] [Related]
17. Relationship between CCL5 and transforming growth factor-β1 (TGFβ1) in breast cancer.
Hartmann MC; Dwyer RM; Costello M; Potter SM; Curran C; Hennessy E; Newell J; Griffin DG; Kerin MJ
Eur J Cancer; 2011 Jul; 47(11):1669-75. PubMed ID: 21658938
[TBL] [Abstract][Full Text] [Related]
18. Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer.
Weng CJ; Chien MH; Lin CW; Chung TT; Zavras AI; Tsai CM; Chen MK; Yang SF
Oral Oncol; 2010 Oct; 46(10):767-72. PubMed ID: 20729133
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
20. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
